CARLSBAD, Calif.--(BUSINESS WIRE)--
Life Technologies Corporation (NASDAQ: LIFE) today announced it will
present at the 29th Annual J.P. Morgan Healthcare Conference
on Tuesday, January 11, at 8:00 a.m. PST. Greg Lucier, Life
Technologies' Chairman and Chief Executive Officer, will present on
behalf of the company. The company will webcast the presentation, which
will be available on the Life Technologies' investor relations website
for two weeks following the conference.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology
tools company dedicated to improving the human condition. Our systems,
consumables and services enable researchers to accelerate scientific
exploration, driving to discoveries and developments that make life even
better. Life Technologies customers do their work across the biological
spectrum, working to advance personalized medicine, regenerative
science, molecular diagnostics, agricultural and environmental research,
and 21st century forensics. Life Technologies had sales of $3.3 billion
in 2009, employs approximately 9,000 people, has a presence in
approximately 160 countries, and possesses a rapidly growing
intellectual property estate of approximately 3,900 patents and
exclusive licenses. Life Technologies was created by the combination of
Invitrogen Corporation and Applied Biosystems Inc., and manufactures
both in-vitro diagnostic products and research use only-labeled
products. For more information on how we are making a difference, please
visit our website: http://www.lifetechnologies.com.
Life Technologies Corporation
Eileen Pattinson, 760-603-7208
ir@lifetech.com
Source: Life Technologies Corporation
News Provided by Acquire Media
